用支架治疗内动脉瘤的指导抗血小板疗法:一个集群随机试验
Yangyang Zhou1,2, Jun Wang3, Wenqiang Li1,2
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring West Road, Fengtai District, Beijing 100070, China.
Radiology
|March 18, 2025
概括
在接受内动脉瘤治疗的患者中,以血小板功能测试为指导的抗血小板治疗显著降低了缺血事件. 这种方法,包括提卡格勒,被证明是安全有效的,降低事件发生率而不会增加出血风险.
科学领域:
- 神经干预外科手术 神经干预外科
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在对内动脉瘤 (IAs) 的神经干预期间,抗血小板药物反应较差会增加缺血事件 (IE) 风险.
- 提卡格勒勒在治疗抗血小板治疗中可能为克洛皮多格雷尔提供更安全的替代品.
- 标准的双重抗血小板治疗 (SDAT) 涉及阿司匹林和克洛皮多格雷尔.
研究的目的:
- 为了评估是否血小板功能测试 (PFT) 引导的抗血小板治疗减少了IE发病率与IA患者的SDAT相比.
- 评估PFT指导治疗在神经干预程序中的疗效和安全性.
主要方法:
- 一个前性的,多中心的,集群随机化试验,涉及16个神经干预团队.
- 试验组:对反应较差的患者进行PFT导向治疗,并调整剂量或切换到蒂卡格勒罗.
- 控制小组:SDAT. 控制小组:SDAT. 控制小组:SDAT. 主要结局:大脑IE在30天内.
主要成果:
- 在30天内,PFT指导组 (6.8%) 与SDAT组 (13.2%) 的IE发病率较低 (OR,0.54;P=.03).
- 在7天内降低了IE发病率 (4.1%对10.8%;OR,0.48;P=.02).
- 修改后的兰金级分数或全因死亡率没有显著差异;两组之间出血事件发生率相似.
结论:
- 以PFT为指导的抗血小板治疗与接受内血管治疗的IA患者中缺血事件的发生率降低有关.
- 作为PFT指导治疗的一部分,切换到蒂卡格勒并没有增加出血事件的风险.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
441
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
441
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
140
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
140
01:22Formation of the Platelet Plug
3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K